Markets for metabolic disorders, botulinum toxins set to soar

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.403, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US neuropathic pain market set to soar

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia

By Brashear Allison

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 241-249

Informa Healthcare

Access to resources Recommend Favorite

Handling Botulinum Toxins: An Updated Literature Review

By TRINDADE DE ALMEIDA ADA R. SECCO LETICIA CARDOSO CARRUTHERS ALASTAIR

Dermatologic Surgery, Vol. 37, Iss. 11, 2011-11 ,pp. : 1553-1565

Elsevier

Access to resources Recommend Favorite

The Medicinal Chemistry of Botulinum, Ricin and Anthrax Toxins

Current Medicinal Chemistry, Vol. 12, Iss. 6, 2005-03 ,pp. : 667-690

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy for overactive bladder: minimally invasive treatment –– botulinum toxins

By Apostolidis Apostolos

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1029-1039

Informa Healthcare

Access to resources Recommend Favorite